abstract |
The present invention relates to novel processes for the preparation 1,3-Thiazol-5- ylmethyl[(2R,5R)-5-{[(2S)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl} carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino} -1,6-diphenylhexan-2-yl] carbamate having the following structural formula- 1 and it's intermediates thereof. |